B

BridgeBio

Develops therapies for genetic diseases

Associate Director - Biostatistics & AI

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • A PhD or Master’s degree in Biostatistics, Statistics, Computer Science, Artificial Intelligence, Data Science, or a closely related quantitative field is required.
  • For the biostatistics-first track, at least 5 years of pharmaceutical biostatistics experience with a PhD or 7 years with a Master’s in drug development, biotech, or CRO settings is required.
  • For the biostatistics-first track, expert-level proficiency in SAS and/or R and working knowledge of Python for data science or scripting are required.
  • For the biostatistics-first track, demonstrated exposure to AI/ML tools such as LLM APIs, prompt engineering, or automation scripting is required.
  • For the AI/ML-first track, at least 3 years of hands-on AI/ML engineering experience, including building and deploying LLM-powered tools, RAG pipelines, agentic workflows, and/or MLOps infrastructure, is required.
  • For the AI/ML-first track, strong Python proficiency for AI/ML development and working familiarity with SAS and/or R in a statistical or data science context are required.
  • For the AI/ML-first track, meaningful exposure to clinical or life sciences data, such as clinical trial datasets, CDISC standards, pharmacovigilance data, or regulated environments (GxP/21 CFR Part 11), is required.
  • For the AI/ML-first track, foundational understanding of statistical concepts relevant to clinical development, such as hypothesis testing, regression, and survival analysis, is required.
  • Strong knowledge of statistical methodologies, current drug development trends, and regulatory environments (FDA, EMA, and ICH) is required.
  • Strong written and verbal communication skills and ability to engage technical and non-technical audiences are required.
  • Ability to work as part of a cross-functional team in a fast-paced environment and collaborate effectively with external partners and vendors is required.
  • Genuine curiosity and initiative in building and deploying AI-powered tools, rather than only adopting them, is required.

Responsibilities

  • Apply appropriate statistical methodologies supporting medical insights, value demonstration, safety monitoring, and lifecycle management.
  • Contribute to statistical design, analysis, and reporting for Phase II–IV clinical trials, including adaptive designs, Bayesian methods, and estimands under ICH E9(R1).
  • Contribute to NDA, BLA, MAA, and other global regulatory submissions as lead or co-statistician, and support responses to health authority queries.
  • Stay current with FDA, EMA, and ICH guidance on statistical methodology and real-world evidence.
  • Design and implement AI/ML interface environments connecting biometric platforms (SAS, R, and Python) with enterprise LLM APIs, RAG pipelines, and clinical data repositories.
  • Build, test, and iterate on AI-powered tools for SAP drafting, TFL automation, anomaly detection, protocol deviation identification, and regulatory document support.
  • Establish and maintain MLOps pipelines for model development, validation, deployment, and monitoring within a GxP-compliant, audit-ready framework.
  • Implement AI governance standards including explainability (SHAP/XAI), bias assessment, and 21 CFR Part 11 / EU Annex 11-compliant documentation.
  • Evaluate and deploy AI-powered automation for CDISC mapping, data cleaning, and submission package preparation.
  • Partner with IT and third-party vendors to integrate AI tools with EDC, CTMS, RTSM, and pharmacovigilance systems.
  • Translate statistical and AI concepts into clear, actionable insights for medical, regulatory, and commercial stakeholders.
  • Partner with Clinical Development, Regulatory Affairs, Medical Affairs, and Pharmacovigilance to align biometrics and AI deliverables with program timelines.
  • Develop and maintain SOPs, work instructions, and best practices for biostatistics, AI tooling, and statistical programming.
  • Manage CRO statisticians and programmers on assigned programs.

Desired Qualifications

  • For the biostatistics-first track, deep knowledge of CDISC standards (SDTM, ADaM, and Define-XML) and regulatory submission workflows is desired.
  • For the biostatistics-first track, experience contributing to NDA/BLA/MAA submissions is preferred.
  • For the biostatistics-first track, a strong interest in expanding AI/ML capabilities in a GxP environment is desired.
  • For the AI/ML-first track, eagerness to deepen clinical/life sciences domain expertise is desired.

About the Company

BridgeBio

Develops therapies for genetic diseases

BridgeBio Pharma develops medicines for genetic diseases using a decentralized subsidiary model, where each subsidiary focuses on a specific disease while sharing central resources. It advances multiple drug programs at once by leveraging genome sequencing, molecular biology, and patient data to translate research into therapies that target underlying genetic causes. The company differentiates itself through its independent subsidiary structure with centralized support, combined with data-driven decision making and a culture of transparent, evidence-based testing. Its goal is to bring effective, disease-modifying therapies to patients faster by advancing a diverse pipeline from discovery to commercialization through partnerships and eventual approval.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Palo Alto, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at BridgeBio

See more jobs